#GastroEdPicks Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a RCT @lancetgastrohep.bsky.social https://www.sciencedirect.com/science/article/pii/S246812532400431X?dgcid=rss_sd_all
Comments